Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by bilosellhion Dec 07, 2004 10:38pm

222 Views

Post# 8282358

RE: no accountability = mrmom

with monikers like yours and posts like this in 2001 "Just before I put you on ignore, I am curious why you insist on wasting your time watching and monitoring this board if the stock is such a POS. Don't you have far more important stocks to waste your time on than this one?" https://www.stockhouse.ca/bullboards/viewmessage.asp?no=4295555&symbol=SNW.A&table=LIST&all=0&t=1&tableid=2 about a company that simply disappeared into thin air, you obviously have a lot of credibility LOL better stick to what you obviously do best - knitting. LMAO

Bullboard Posts

Debt-free cannabis company set for next stage of growth